查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
肺癌篩查市場規模和 2030 年預測 - 按癌症類型、技術、年齡層（50 歲及以上和 50 歲以下）和最終用戶（醫院、診斷中心等）分類的 COVID-19 影響和全球分析
市場調查報告書
商品編碼
1324831

肺癌篩查市場規模和 2030 年預測 - 按癌症類型、技術、年齡層（50 歲及以上和 50 歲以下）和最終用戶（醫院、診斷中心等）分類的 COVID-19 影響和全球分析

Lung Cancer Screening Market Size and Forecast to 2030 - Global Analysis by Cancer Type, Technology, Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)
出版日期: | 出版商: The Insight Partners | 英文 188 Pages | 訂單完成後即時交付

價格

肺癌篩查市場規模預計將從2022年的23.265億美元成長到2030年的43.6395億美元；預計2022年至2030年年複合成長率為8.2%。

肺癌篩查市場的成長歸因於肺癌發病率的上升和政府支持的增加。然而，肺部篩查測試的高成本阻礙了肺癌篩查市場的成長。

肺癌篩查是用於在其他方面健康且患有肺癌高風險的人群中檢測肺癌的過程。建議長期吸煙且沒有任何肺癌體徵或症狀的老年人進行肺癌篩查。醫生使用肺部 LDCT 掃描來尋找肺癌。如果早期發現肺癌，則更有可能通過治療治愈。

政府支持力度的加大正在推動肺癌篩查市場的成長

美國預防服務工作組建議，年齡在55 歲至80 歲之間，有每年30 包（相當於每天吸20 支香煙，持續30 年）吸煙史、目前正在吸煙或在過去15 年內已戒菸的人進行年度低煙度檢查。 - 肺癌劑量電腦斷層掃描（LDCT）篩查。

根據《澳大利亞癌症 2023》報告，肺癌是澳大利亞最常見的癌症，佔死亡率的大部分。此外，早期發現肺癌有助於提高生存率。此外，新的篩查計劃將有助於在治療不太可能成功的早期階段發現肺癌。例如，2021 年 7 月，澳大利亞癌症協會與健康和老年護理部合作，確定澳大利亞肺癌篩查計劃的可行性。

政府不斷增加的支持、政策和多國政府的批准正在推動肺癌篩查市場的成長。

肺癌篩查市場 - 癌症類型洞察

根據癌症類型，肺癌篩查市場分為非小細胞肺癌和小細胞肺癌。 NSCLC 細分市場在 2022 年佔據最大市場佔有率，預計在預測期內年複合成長率為 10.3%。該細分市場的市場地位歸因於全球非小細胞肺癌病例的不斷增加。 NSCLC 的發展速度比小細胞肺癌慢。在確診時，它通常會擴散到患者身體的其他部位。因此，早期診斷和治療至關重要。根據美國國家癌症研究基金會的數據，每 10 例診斷中就有近 9 例患有非小細胞肺癌。根據同一來源，大細胞未分化癌肺癌約佔所有 NSCLC 診斷的 10-15%。

肺癌篩查市場 - 技術洞察

根據技術，肺癌篩查市場分為LDCT、胸部X光檢查、液體活體組織切片等。 LDCT 在 2022 年佔據最大市場佔有率，預計在預測期內年複合成長率為 8.0%。

肺癌篩查市場 - 年齡層洞察

根據年齡層，肺癌篩查市場分為 50 歲及以上和 50 歲以下。 2022 年，50 歲及以上細分市場佔據最大市場佔有率，但 50 歲以下人群預計將以 8.9% 的年複合成長率成長預測期。

肺癌篩查市場 - 最終用戶洞察

根據最終用戶，肺癌篩查市場分為醫院、診斷中心等。到 2022 年，醫院細分市場佔據最大市場佔有率，但其他細分市場預計在預測期內將以 8.7% 的年複合成長率成長。

肺癌篩查市場 - 最新動態：

肺癌篩查市場的公司高度採用併購等無機和有機策略。下面列出了最近的一些主要市場發展：

2021年11月，GE醫療與Optellum合作推進肺癌精準診斷和治療。兩家公司正在共同尋求解決診斷肺癌的最大挑戰之一，幫助提供者確定肺結節的惡性程度：可能是良性或癌性的可疑病變。

2022年6月，皇家飛利浦與Biodesix, Inc.合作，將Biodesix的Nodify Lung基於血液的肺結節風險評估測試結果涵蓋飛利浦Lung Cancer Orchestrator肺癌患者管理系統。蛋白質組學數據的結合- 以及目前用於確定治療決策的放射學和患者病史數據，可以通過在Biodesix Nodify Lung 應用程式中的上下文啟動，幫助癌症護理中心在管理越來越多的肺結節病例方面提高診斷效率。肺癌協調員。

2021年5月，泛生子控股有限公司與西門子醫療攜手亮相中國醫療器械博覽會。此次合作旨在推動泛生子S5平台和肺癌8基因IVD檢測在中國醫院的大規模應用，為非小細胞肺癌（NSCLC）患者提供高效、準確的個性化診療指導。

目錄

第 1 章：簡介

  • 研究範圍
  • Insight Partners 研究報告指南
  • 市場細分
    • 全球肺癌篩查市場 - 按技術分類
    • 全球肺癌篩查市場 - 按癌症類型
    • 全球肺癌篩查市場 - 按年齡段
    • 全球肺癌篩查市場 - 按最終用戶分類
    • 全球肺癌篩查市場 - 按地理位置

第 2 章：肺癌篩查市場 - 要點

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：肺癌篩查市場 - 市場格局

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 歐洲PEST分析
    • 亞太地區 PEST 分析
    • 南美洲和中美洲 PEST 分析
    • 中東和非洲 PEST 分析
  • 專家意見

第 5 章：肺癌篩查市場 - 主要市場動態

  • 市場促進因素
    • 肺癌發病率上升
    • 增加政府支持
  • 市場限制
    • 肺癌篩查測試成本高昂
  • 市場機會
    • 結構化肺癌篩查計劃
  • 未來的趨勢
    • 移動肺癌篩查車
  • 影響分析

第 6 章：肺癌篩查市場 - 全球分析

  • 全球肺癌篩查市場收入預測與分析
  • 全球肺癌篩查市場（按地理位置）-預測與分析

第 7 章：全球肺癌篩查市場 - 2028 年收入和預測 - 按癌症類型

  • 概述
  • 2022 年和 2030 年按癌症類型分類的肺癌篩查市場收入佔有率 (%)
  • 非小細胞肺癌 (NSCLC)
  • 小細胞肺癌

第 8 章：肺癌篩查市場分析 - 按技術

  • 概述
  • 低劑量電腦斷層掃描 (LDCT)
  • 胸部X光檢查
  • 液體活體組織切片
  • 其他

第 9 章：肺癌篩查市場分析 - 按年齡層

  • 概述
  • 及較舊的
  • 50以下

第 10 章：肺癌篩查市場分析 - 按最終用戶

  • 概述
  • 醫院
  • 診斷中心
  • 其他

第 11 章：肺癌篩查市場 - 2028 年收入和預測 - 地理分析

  • 北美
    • 我們
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 亞太地區其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 12 章：COVID-19 前後對肺癌篩查市場的影響

  • COVID-19疫情對肺癌篩查市場的影響分析

第 13 章：肺癌篩查市場-行業格局

  • 近期成長策略
    • 概述

第 14 章：公司簡介

  • Intelerad Medical Systems
  • Nuance Communications Inc
  • GE HealthCare
  • Medtronic
  • Canon Inc.
  • Koninklijke Philips NV
  • Siemens AG
  • CVS Health
  • bioAffinity Technologies, Inc.
  • LungLife AI, Inc.

第 15 章：附錄

  • 關於 Insight Partners
  • 專業術語
Product Code: TIPRE00029996

The lung cancer screening market size is expected to grow from US$ 2,326.5 million in 2022 to US$ 4,363.95 million by 2030; it is estimated to record a CAGR of 8.2% from 2022 to 2030.

The lung cancer screening market growth is attributed to the rising lung cancer Incidence and increasing government support. However, the high cost of lung screening tests is hampering the growth of the lung cancer screening market.

Lung cancer screening is a process used to detect lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening is recommended for older adults who are long time smokers and who don't have any signs or symptoms of lung cancer. Doctors use a LDCT scan of the lungs to look for lung cancer. If lung cancer is detected early, it's more likely to be cured with treatment.

Rising Government Supportis Boosting The Growth Of The Lung Cancer Screening Market

The United States Preventive Services Task Force recommends people aged 55-80 with a 30-pack-year (equivalent to smoking 20 cigarettes per day for 30 years) smoking history who are presently smoking or have quit within the last 15 years to undergo annual low-dose computed tomography (LDCT) screening for lung cancer.

As per the Cancer Australia 2023 report, lung cancer is the most common form of cancer in Australia, accounting for the majority of the mortality rates. Furthermore, early detection of lung cancer helps improve survival rates. Also, the new screening program will help detect lung cancer during the early stages when treatment is not likely to be successful. For example, in July 2021, Cancer Australia partnered with the Department of Health and Aged Care to determine the feasibility of a lung cancer screening program in Australia.

Such rising government support, policies, and approvals by several governments are boosting the growth of the lung cancer screening market.

Lung Cancer Screening Market - Cancer Type Insights

Based on cancer type, the lung cancer screening market is bifurcated into NSCLC and small cell lung cancer. The NSCLC segment accounted for the largest market share in 2022 and is expected to grow at a CAGR of 10.3% during the forecast period. The market position of this segment is due to the rising cases of NSCLC over the globe. NSCLC develops more slowly than small cell lung cancer. It usually spreads to other parts of the patient's body by the time it is diagnosed. Therefore, early diagnosis and treatment are crucial. According to National Foundation for Cancer Research, NSCLC accounts for nearly 9 out of every 10 diagnoses. As per the same source, large-cell undifferentiated carcinoma lung cancer accounts for approximately 10-15% of all NSCLC diagnoses.

Lung Cancer Screening Market - Technology Insights

Based on technology, the Lung cancer screening market is segmented into LDCT, chest X-ray, liquid biopsy, and others. The LDCT accounted for the largest market share in 2022 and same is expected to grow at a CAGR of 8.0% during the forecast period.

Lung Cancer Screening Market - Age Group Insights

Based on age group, the lung cancer screening market is bifurcated into 50 & older and below 50. The 50 & older segment accounted for the largest market share in 2022, however, the below 50 is expected to grow at a CAGR of 8.9% during the forecast period.

Lung Cancer Screening Market - End User Insights

Based on end user, the lung cancer screening market is segmented into hospitals, diagnostic centers, and others. The hospitals segment accounted for the largest market share in 2022, however, the others is expected to grow at a CAGR of 8.7% during the forecast period.

Lung Cancer Screening Market - Recent Developments:

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the lung cancer screening market. A few recent key market developments are listed below:

In November 2021, GE Healthcare and Optellum collaborated to advance precision diagnosis and treatment of lung cancer. Together, the companies are seeking to address one of the largest challenges in diagnosing lung cancer, helping providers to determine the malignancy of a lung nodule: a suspicious lesion that may be benign or cancerous.

In June 2022, Royal Philips teamed up with Biodesix, Inc. to incorporate the results of Biodesix's Nodify Lung blood-based lung nodule risk assessment testing into Philips Lung Cancer Orchestrator lung cancer patient management system. The incorporation of proteomics data - along with the radiologic and patient history data currently used to determine treatment decisions can help create diagnostic efficiency for cancer care centers in the management of a growing number of lung nodule cases via the contextual launch of Biodesix Nodify Lung application within Lung Cancer Orchestrator.

In May 2021, Genetron Holdings Limited has partnered with Siemens Healthineers at the China Medical Equipment Fair. This partnership aims to promote the large-scale application of Genetron's S5 platform and lung cancer 8-gene IVD assay in Chinese hospitals to provide non-small cell lung cancer (NSCLC) patients with efficient and accurate personalized diagnosis and treatment guidance.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the lung cancer screening market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the lung cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Lung Cancer Screening Market - by Technology
    • 1.3.2 Global Lung Cancer Screening Market - by Cancer Type
    • 1.3.3 Global Lung Cancer Screening Market - by Age Group
    • 1.3.4 Global Lung Cancer Screening Market - by End User
    • 1.3.5 Global Lung Cancer Screening Market - by Geography

2. Lung Cancer Screening Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Lung Cancer Screening Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis
  • 4.3 Expert's Opinion

5. Lung Cancer Screening Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Lung Cancer Incidences
    • 5.1.2 Increasing Government Support
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Lung Cancer Screening Tests
  • 5.3 Market Opportunities
    • 5.3.1 Structured Lung Cancer Screening Program
  • 5.4 Future Trends
    • 5.4.1 Mobile Lung Cancer Screening Truck
  • 5.5 Impact Analysis

6. Lung Cancer Screening Market - Global Analysis

  • 6.1 Global Lung Cancer Screening Market Revenue Forecast and Analysis
  • 6.2 Global Lung Cancer Screening Market, by Geography - Forecast and Analysis

7. Global Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type

  • 7.1 Overview
  • 7.2 Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
  • 7.3 Non-Small Cell Lung Cancer (NSCLC)
    • 7.3.1 Overview
    • 7.3.2 Non-Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Mn)
  • 7.4 Small Cell Lung Cancer
    • 7.4.1 Overview
    • 7.4.2 Small Cell Lung Cancer: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Lung Cancer Screening Market Analysis - by Technology

  • 8.1 Overview
  • 8.2 Low-Dose Computed Tomography (LDCT)
    • 8.2.1 Overview
    • 8.2.2 Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Chest X-ray
    • 8.3.1 Overview
    • 8.3.2 Chest X-ray: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Liquid Biopsy
    • 8.4.1 Overview
    • 8.4.2 Liquid Biopsy: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)

9. Lung Cancer Screening Market Analysis - by Age Group

  • 9.1 Overview
  • 9.2 & Older
    • 9.2.1 Overview
    • 9.2.2 & Older: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Below 50
    • 9.3.1 Overview
    • 9.3.2 Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

10. Lung Cancer Screening Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospitals
    • 10.2.1 Overview
    • 10.2.2 Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Others
    • 10.4.1 Overview
    • 10.4.2 Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

11. Lung Cancer Screening Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 11.1 North America: Lung Cancer Screening Market
    • 11.1.1 Overview
    • 11.1.2 North America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.1.3 North America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    • 11.1.4 North America: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
    • 11.1.5 North America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    • 11.1.6 North America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.6.1 US: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.1.1 Overview
        • 11.1.6.1.2 US: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.1.3 US: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.6.1.4 US: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.1.5 US: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.6.1.6 US: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.6.2 Canada: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.2.1 Overview
        • 11.1.6.2.2 Canada: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.2.3 Canada: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.6.2.4 Canada: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.2.5 Canada: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.6.2.6 Canada: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.6.3 Mexico: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.3.1 Overview
        • 11.1.6.3.2 Mexico: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.3.3 Mexico: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.6.3.4 Mexico: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.3.5 Mexico: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.6.3.6 Mexico: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.2 Europe: Lung Cancer Screening Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.2.3 Europe: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    • 11.2.4 Europe: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
    • 11.2.5 Europe: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    • 11.2.6 Europe: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.1 Germany: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.1.1 Overview
        • 11.2.6.1.2 Germany: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.1.3 Germany: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.2.6.1.4 Germany: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.1.5 Germany: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.2.6.1.6 Germany: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.2 UK: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.2.1 Overview
        • 11.2.6.2.2 UK: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.2.3 UK: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.2.6.2.4 UK: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.2.5 UK: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.2.6.2.6 UK: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.3 France: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.3.1 Overview
        • 11.2.6.3.2 France: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.3.3 France: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.2.6.3.4 France: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.3.5 France: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.2.6.3.6 France: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.4 Italy: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.4.1 Overview
        • 11.2.6.4.2 Italy: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.4.3 Italy: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.2.6.4.4 Italy: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.4.5 Italy: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.2.6.4.6 Italy: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.5 Spain: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.5.1 Overview
        • 11.2.6.5.2 Spain: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.5.3 Spain: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.2.6.5.4 Spain: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.5.5 Spain: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.2.6.5.6 Spain: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.6 Rest of Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.6.1 Overview
        • 11.2.6.6.2 Rest of Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.6.3 Rest of Europe: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.2.6.6.4 Rest of Europe: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.6.5 Rest of Europe: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.2.6.6.6 Rest of Europe: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.3 Asia-Pacific: Lung Cancer Screening Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.3.3 Asia Pacific: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    • 11.3.4 Asia Pacific: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
    • 11.3.5 Asia Pacific: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    • 11.3.6 Asia Pacific: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.1 China: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.1.1 Overview
        • 11.3.6.1.2 China: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.1.3 China: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.3.6.1.4 China: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.1.5 China: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.3.6.1.6 China: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.2 Japan: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.2.1 Overview
        • 11.3.6.2.2 Japan: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.2.3 Japan: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.3.6.2.4 Japan: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.2.5 Japan: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.3.6.2.6 Japan: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.3 India: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.3.1 Overview
        • 11.3.6.3.2 India: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.3.3 India: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.3.6.3.4 India: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.3.5 India: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.3.6.3.6 India: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.4 Australia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.4.1 Overview
        • 11.3.6.4.2 Australia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.4.3 Australia: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.3.6.4.4 Australia: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.4.5 Australia: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.3.6.4.6 Australia: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.5 South Korea: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.5.1 Overview
        • 11.3.6.5.2 South Korea: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.5.3 South Korea: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.3.6.5.4 South Korea: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.5.5 South Korea: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.3.6.5.6 South Korea: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.6 Rest of Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.6.1 Overview
        • 11.3.6.6.2 Rest of Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.6.3 Rest of Asia Pacific: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.3.6.6.4 Rest of Asia Pacific: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.6.5 Rest of Asia Pacific: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.3.6.6.6 Rest of Asia Pacific: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.4 Middle East & Africa: Lung Cancer Screening Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.4.3 Middle East & Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    • 11.4.4 Middle East & Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
    • 11.4.5 Middle East & Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.4.5.1.1 Middle East & Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.5.2 South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.2.1 Overview
        • 11.4.5.2.2 South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.2.3 South Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.4.5.2.4 South Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.5.2.5 South Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.4.5.2.6 South Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.5.3 Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.3.1 Overview
        • 11.4.5.3.2 Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.3.3 Saudi Arabia: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.4.5.3.4 Saudi Arabia: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.5.3.5 Saudi Arabia Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.4.5.3.6 Saudi Arabia: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.5.4 UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.4.1 Overview
        • 11.4.5.4.2 UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.4.3 UAE: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.4.5.4.4 UAE: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.5.4.5 UAE Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.4.5.4.6 UAE: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.5.5 Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.5.1 Overview
        • 11.4.5.5.2 Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.5.3 Rest of Middle East & Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.4.5.5.4 Rest of Middle East & Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.5.5.5 Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.4.5.5.6 Rest of Middle East & Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.5 South & Central America: Lung Cancer Screening Market
    • 11.5.1 Overview
    • 11.5.2 South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.5.3 South & Central America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    • 11.5.4 South & Central America: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
    • 11.5.5 South & Central America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    • 11.5.6 South & Central America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.5.6.1 Brazil: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.1.1 Overview
        • 11.5.6.1.2 Brazil: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.1.3 Brazil: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.5.6.1.4 Brazil: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.1.5 Brazil: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.5.6.1.6 Brazil: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.5.6.2 Argentina: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.2.1 Overview
        • 11.5.6.2.2 Argentina: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.2.3 Argentina: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.5.6.2.4 Argentina: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.2.5 Argentina: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.5.6.2.6 Argentina: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.5.6.3 Rest of South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.3.1 Overview
        • 11.5.6.3.2 Rest of South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.3.3 Rest of South & Central America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.5.6.3.4 Rest of South & Central America: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.3.5 Rest of South & Central America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.5.6.3.6 Rest of South & Central America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

12. Pre and Post COVID-19 Impact on Lung Cancer Screening Market

  • 12.1 Impact Analysis of COVID-19 Pandemic on Lung Cancer Screening Market

13. Lung Cancer Screening Market-Industry Landscape

  • 13.1 Recent Growth Strategies
    • 13.1.1 Overview

14. Company Profiles

  • 14.1 Intelerad Medical Systems
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Nuance Communications Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 GE HealthCare
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Medtronic
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Canon Inc.
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Koninklijke Philips NV
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Siemens AG
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 CVS Health
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 bioAffinity Technologies, Inc.
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 LungLife AI, Inc.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. North America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 2. North America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 6. US Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 10. Canada Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 14. Mexico Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Europe Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Europe Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Europe Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Germany Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 22. Germany Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Germany Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Germany Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. UK Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 26. UK Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. UK Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. UK Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. France Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 30. France Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. France Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. France Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Italy Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 34. Italy Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Italy Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Italy Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Spain Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 38. Spain Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Spain Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Spain Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Rest of Europe Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 42. Rest of Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Rest of Europe Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Rest of Europe Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. China Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 50. China Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. China Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. China Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Japan Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 54. Japan Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Japan Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Japan Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. India Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 58. India Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. India Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. India Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Australia Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 62. Australia Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Australia Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Australia Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. South Korea Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 66. South Korea Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. South Korea Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. South Korea Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Rest of Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 70. Rest of Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Rest of Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Rest of Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Middle East & Africa Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Middle East & Africa Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Middle East & Africa Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Middle East & Africa Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. South Africa Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. South Africa Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. South Africa Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. South Africa Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. Saudi Arabia Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Saudi Arabia Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Saudi Arabia Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Saudi Arabia Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. UAE Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. UAE Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. UAE Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. UAE Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. Rest of Middle East & Africa Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. Rest of Middle East & Africa Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Middle East & Africa Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. Brazil Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 98. Brazil Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Brazil Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. Brazil Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. Argentina Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 102. Argentina Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. Argentina Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. Argentina Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. Rest of South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 106. Rest of South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Rest of South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Rest of South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Recent Growth Strategies in the Lung Cancer Screening Market
  • Table 110. Glossary of Terms

List Of Figures

  • Figure 1. Lung Cancer Screening Market Segmentation
  • Figure 2. Lung Cancer Screening Market, by Region
  • Figure 3. Global Lung Cancer Screening Market Overview
  • Figure 4. Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Lung Cancer Screening Market
  • Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Lung Cancer Screening Market, by Geography (US$ Million)
  • Figure 7. Global Lung Cancer Screening Market - Leading Country Markets (US$ Million)
  • Figure 8. North America: PEST Analysis
  • Figure 9. Europe: PEST Analysis
  • Figure 10. Asia Pacific: PEST Analysis
  • Figure 11. South & Central America: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. Experts' Opinion
  • Figure 14. Lung Cancer Screening Market Impact Analysis of Driver and Restraints
  • Figure 15. Global Lung Cancer Screening Market - Revenue Forecast and Analysis - 2020-2030
  • Figure 16. Global Lung Cancer Screening Market, by Geography - Forecast and Analysis (2022 & 2030)
  • Figure 17. Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
  • Figure 18. Non-Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Small Cell Lung Cancer: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
  • Figure 21. Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Chest X-ray: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Liquid Biopsy: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
  • Figure 26. & Older: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
  • Figure 29. Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. North America: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 33. North America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. North America: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
  • Figure 35. US: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Canada: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Mexico: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Europe: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 39. Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Europe: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
  • Figure 41. Germany: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 42. UK: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 43. France: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 44. Italy: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. Spain: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 46. Rest of Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 47. Asia Pacific: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 48. Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 49. Asia Pacific: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
  • Figure 50. China: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 51. Japan: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 52. India: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 53. Australia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 54. South Korea: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 55. Rest of Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 56. Middle East & Africa: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 57. Middle East & Africa Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 58. Middle East & Africa: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
  • Figure 59. South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 60. Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 61. UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 62. Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 63. South & Central America: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 64. South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 65. South & Central America: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
  • Figure 66. Brazil: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 67. Argentina: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 68. Rest of South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 69. Pre and Post Impact of COVID-19 Pandemic on Markets